Autoimmune disease Clinical Trials
Recruiting autoimmune disease studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat autoimmune disease. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting autoimmune disease studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting autoimmune disease trials
ACT for Veterans With IBD and Mental Health Challenges
Digital Mind Body Intervention Among Black and Hispanic Patients Living With Inflammatory Bowel Disease
Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis
Autoimmune Disease Treatment With Mesenchymal Stem Cells (MSCs) and CAR-T Cells
CAR-T Cells Targeting Autoimmune Diseases
Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to Severe Atopic Dermatitis
LMT503 First-in-human SAD, MAD, and FE Study
Exercise With and Without Cognitive Training
Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune Diseases
Efficacy and Safety of HN2301 in Patients With Generalized Myasthenia Gravis (MG)
MIRICURE: Mirikizumab With Curettage and Repair (Closure) for Perianal Fistulizing Crohn's Disease
Continued Access to Deucravacitinib for Adult SLE/SjD and Pediatric PsO/PsA Study Completers
Apremilast and Adalimumab in Psoriatic Arthritis Patients
Lead Exposure and Multiple Sclerosis
Safety and Tolerability of a Single Intravenous Infusion of BX-U001 in Refractory Rheumatoid Arthritis
Autologous Hematopoietic Stem Cell Transplantation for Refractory Multiple Sclerosis
Chronic Fatigue in Multiple Sclerosis: MS Copilot Boost Solution Compared to Standard Care
An AI-Based Erythema Measurement System for Psoriasis Lesions
Ex Vivo Study of hAMSC Secretome in Inflammatory Bowel Disease: Effects on Inflammation and Fibrosis (TARGET)
Assessing Psoriasis Treatment Outcomes
A Biosimilar Trial to Investigate PK, PD, Safety With PB018 Versus US-licensed Ocrevus and EU-approved Ocrevus
A Study of SL-325 in Crohn's Disease Patients
Serum Asprosin, Metabolic Syndrome, and Cardiometabolic Risk in Rheumatoid Arthritis
Disease Impact and Its Correlation With Disease Activity in Psoriatic Arthritis
Subclinical Hypothyroidism and Disease Activity in Rheumatoid Arthritis
Study to Characterise Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Anifrolumab Administered Subcutaneously (SC) or Intravenously (IV)
A Study to Evaluate the Equivalence of IBI3027 and Dupilumab Injection in Participants With Moderate to Severe Atopic Dermatitis
A Study of Early Secukinumab Treatment in Moderate to Severe Hidradenitis Suppurativa Patients
Medical Treatment Versus Surgery in Stricturing Small Bowel Crohn's Disease
A Study to Investigate the Efficacy and Safety Profile of GM-XANTHO [GM-XAN003] in Patients With Psoriasis
Saphnelo Use in Females of Child-bearing Potential
Cognitive Musical Screening and Therapeutic Innovation in Multiple Sclerosis
Evaluation of Serum IL-41 Level in Patients With Ankylosing Spondylitis and Psoriatic Arthritis
Combination CurQD and Vedolizumab in Ulcerative Colitis
Physical Activity Intervention for Individuals Newly Diagnosed With MS
Development and Evaluation of the Effectiveness of the SMART-HAND Protocol for Hand Rehabilitation in Patients With Rheumatoid Arthritis
Cone Evasion Walk Test in Multiple Sclerosis
Artificial Intelligence For Outcomes Research in Crohn's Disease: Digital Pathology Assessment of Fibrosis and Association With Patient History and Clinical Outcomes
Capillary Sampling in Clinical Populations Undergoing Monitoring
Hyperbaric Oxygen Therapy for Perianal Fistulizing Crohn's Disease Not Responsive or Intolerant to Conventional Care: HYPNOTIC Pilot Study
A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology
Disulfiram in Rheumatoid Arthritis
Effectiveness of Upadacitinib and Biologics for the Achievement of Minimal Disease Activity in Adults With Moderate-to-Severe Atopic Dermatitis (RAMpUp)
A Study of Continued Use of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis in Real World Setting
Evaluating the Use of Oral Indapamide to Reduce Disabiltiy Progression in Progressive Multiple Sclerosis (MS)
Effects of Kefir on Celiac Disease
Inflammation, Autoimmunity and Healthy Ageing in Menopause Transition. An Observational, Cross-sectional Study
Inflammatory Biomarkers and Disease Activity in Inflammatory Bowel Disease
Mediterranean Dietary Intervention for HS
Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Subjects With Moderate-to-severe Atopic Dermatitis
A Study on Infections in Adults With Ulcerative Colitis/Crohn's Disease
Phase Ib/II Study of SYS6020 in Relapsing/Refractory Multiple Sclerosis
A Real-world Study of Patients With Hidradenitis Suppurativa and High Cardiovascular Risk or Established Coronary Plaque Treated With Secukinumab
A Trial in Healthy Adult Participants and Adults With Autoimmune Disease to Test How HBM7020 is Tolerated and Absorbed in the Body
A Study of Guselkumab Given After Ustekinumab in Participants With Moderate to Severe Psoriasis in Routine Clinical Practice
PLasmatic Extracellular Vesicles AS Biomarkers of nEural Tissue Damage
Effects of Face-to-Face Versus Telerehabilitation-Based Circuit Training in People With Multiple Sclerosis
A Study to Learn About a Medicine Called PF-08154225 in Participants With Autoimmune Diseases
Deciphering the Genetic Architecture of Autoimmune Diseases
New trials in Birmingham, AL?
Pick a condition and we'll email you once a week when a new study starts recruiting in Birmingham, AL. Unsubscribe anytime.
Autoimmune disease clinical trials — common questions
Are autoimmune disease clinical trials free to join?
Yes. Participating in a autoimmune disease clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a autoimmune disease clinical trial?
Each autoimmune disease study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a autoimmune disease trial near me?
Use the location controls above. We'll show recruiting autoimmune disease trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many autoimmune disease trials are recruiting right now?
We're currently tracking roughly 663 recruiting autoimmune disease trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.